Search

The relationship among oxidative stress, inflammations and stone formation has been proved. Mitochondria, as one of the most important organelles in cell, plays an important role in energy supply, oxidative stress, calcium homeostasis and cell programmed death. Mitochondrial dysfunction may accelerate the kidney stone-forming, which may be related to the decreased antioxidant capacity, the activation of inflammatory pathways, the imbalance of intracellular calcium and oxalic acid homeostasis. To clarify the roles of mitochondrial dysfunction in the formation of kidney stones may support the research on pathogenesis of the disease and to provide some potential novel ideas in the prophylactic study of renal stone in future.

The mitochondrion serves as a critical intracellular organelle, engaging in essential roles in the regulation of energy production, oxidative stress management, calcium homeostasis, and apoptosis. One such disease that has been particularly associated with these functions is kidney stone disease (KSD), specifically calcium oxalate (CaOx). It is underpinned by oxidative stress and tissue inflammation. Recent studies have shed light on the vital involvement of mitochondrial dysfunction, the nucleotide‐binding domain and leucine‐rich repeat containing protein 3 (NLRP3) inflammasome, endoplasmic reticulum stress and subsequent cell death in CaOx crystal retention and aggregation. These processes are pivotal in the pathogenesis of kidney stone formation. This review focuses on the pivotal roles of mitochondria in renal cell functions and provides an overview of the intricate interconnectedness between mitochondrial dysfunction and NLRP3 inflammasome activation in the context of KSD. It is essential to recognise the utmost significance of gaining a comprehensive understanding of the mechanisms that safeguard mitochondrial function and regulate the NLRP3 inflammasome. Such knowledge carries significant scientific implications and opens up promising avenues for the development of innovative strategies to prevent the formation of kidney stones. [ABSTRACT FROM AUTHOR]

AbstractPolyolefin elastomers are typically copolymers of ethylene with 1-butene, 1-hexene, or 1-octene. Other types of comonomers have not been widely applied industrially. The cost of 1-heptene obtained from Fischer-Tropsch synthesis is only half that of 1-octene, making it a viable economical substitute. This work utilized 1-heptene from Fischer-Tropsch synthesis and 1-octene from ethylene oligomerization as research subjects. Eight metallocene POEs based on 1-heptene and 1-octene were synthesized using Me2Si(C5Me4)(NtBu)]TiCl2 (Ti-CGC) catalyst. The copolymers’ molecular structures and physical properties were characterized using HT-GPC, Temperature Rising Elution Fractionation (TREF),13C-NMR, DSC, Melt Index (MI), and Tensile tests. Compared to 1-heptene, 1-octene more effectively reduces the melting point and crystallinity, while 1-heptene’s stronger comonomer insertion capability facilitates the production of copolymers with higher comonomer content. Similar ternary sequence distributions and molecular dynamics indicate that ethylene/1-heptene and ethylene/1-octene copolymers possess comparable chain microstructures. Both ethylene/1-heptene copolymers and ethylene/1-octene copolymers exhibit excellent toughness and mechanical properties. Although the activity and insertion capacity of ethylene and 1-heptene decrease at low comonomer concentrations, they significantly improve at higher comonomer concentrations. Thus, Fischer-Tropsch synthesis of metallocene ethylene/1-heptene copolymers can effectively reduce raw material costs and be a cost-effective alternative to ethylene/1-octene copolymers. [ABSTRACT FROM AUTHOR]

Prunella vulgaris L. (PV) is a widely distributed plant species, known for its versatile applications in both traditional and contemporary medicine, as well as in functional food development. Despite its broad-spectrum antimicrobial utility, the specific mechanism of antibacterial action remains elusive. To fill this knowledge gap, the present study investigated the antibacterial properties of PV extracts against methicillin-resistant Staphylococcus aureus (MRSA) and assessed their mechanistic impact on bacterial cells and cellular functions. The aqueous extract of PV demonstrated greater anti-MRSA activity compared to the ethanolic and methanolic extracts. UPLC-ESI-MS/MS tentatively identified 28 phytochemical components in the aqueous extract of PV. Exposure to an aqueous extract at ½ MIC and MIC for 5 h resulted in a significant release of intracellular nucleic acid (up to 6-fold) and protein (up to 10-fold) into the extracellular environment. Additionally, this treatment caused a notable decline in the activity of several crucial enzymes, including a 41.51% reduction in alkaline phosphatase (AKP), a 45.71% decrease in adenosine triphosphatase (ATPase), and a 48.99% drop in superoxide dismutase (SOD). Furthermore, there was a decrease of 24.17% at ½ MIC and 27.17% at MIC in tricarboxylic acid (TCA) cycle activity and energy transfer. Collectively, these findings indicate that the anti-MRSA properties of PV may stem from its ability to disrupt membrane and cell wall integrity, interfere with enzymatic activity, and impede bacterial cell metabolism and the transmission of information and energy that is essential for bacterial growth, ultimately resulting in bacterial apoptosis. The diverse range of characteristics exhibited by PV positions it as a promising antimicrobial agent with broad applications for enhancing health and improving food safety and quality. [ABSTRACT FROM AUTHOR]

Nephrolithiasis is a major public health concern associated with high morbidity and recurrence. Despite decades of research, the pathogenesis of nephrolithiasis remains incompletely understood, and effective prevention is lacking. An increasing body of evidence suggests that non-coding RNAs, especially microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), play a role in stone formation and stone-related kidney injury. MiRNAs have been studied quite extensively in nephrolithiasis, and a plethora of specific miRNAs have been implicated in the pathogenesis of nephrolithiasis, involving remarkable changes in calcium metabolism, oxalate metabolism, oxidative stress, cell–crystal adhesion, cellular autophagy, apoptosis, and macrophage (Mp) polarization and metabolism. Emerging evidence suggests a potential for miRNAs as novel diagnostic biomarkers of nephrolithiasis. LncRNAs act as competing endogenous RNAs (ceRNAs) to bind miRNAs, thereby modulating mRNA expression to participate in the regulation of physiological mechanisms in kidney stones. Small interfering RNAs (siRNAs) may provide a novel approach to kidney stone prevention and treatment by treating related metabolic conditions that cause kidney stones. Further investigation into these non-coding RNAs will generate novel insights into the mechanisms of renal stone formation and stone-related renal injury and might lead to new strategies for diagnosing and treating this disease. [ABSTRACT FROM AUTHOR]